Abstract:Objectives: Anti-melanoma differentiation-associated gene 5 antibody-positive (anti-MDA5(+)) DM complicated by rapidly progressive interstitial lung disease (RP-ILD) has a high incidence and poor prognosis. The objective of this study was to establish a model for the prediction and early diagnosis of anti-MDA5(+) DM-associated RP-ILD based on clinical manifestations and imaging features. Methods: A total of 103 patients with anti-MDA5(+) DM were included. The patients were randomly split into training and testing sets of 72 and 31 patients, respectively. After image analysis, we collected clinical, imaging and radiomics features from each patient. Feature selection was performed first with the minimum redundancy and maximum relevance algorithm and then with the best subset selection method. The final remaining features comprised the radscore. A clinical model and imaging model were then constructed with the selected independent risk factors for the prediction of non-RP-ILD and RP-ILD. We also combined these models in different ways and compared their predictive abilities. A nomogram was also established. The predictive performances of the models were assessed based on receiver operating characteristics curves, calibration curves, discriminability and clinical utility. Results: The analyses showed that two clinical factors, dyspnoea (P=0.000) and duration of illness in months (P=0.001), and three radiomics features (P=0.001, 0.044 and 0.008, separately) were independent predictors of non-RP-ILD and RP-ILD. However, no imaging features were significantly different between the two groups. The radiomics model built with the three radiomics features performed worse than the clinical model and showed areas under the curve (AUCs) of 0.805 and 0.754 in the training and test sets, respectively. The clinical model demonstrated a good predictive ability for RP-ILD in MDA5(+) DM patients, with an AUC, sensitivity, specificity and accuracy of 0.954, 0.931, 0.837 and 0.847 in the training set and 0.890, 0.875, 0.800 and 0.774 in the testing set, respectively. The combination model built with clinical and radiomics features performed slightly better than the clinical model, with an AUC, sensitivity, specificity and accuracy of 0.994, 0.966, 0.977 and 0.931 in the training set and 0.890, 0.812, 1.000 and 0.839 in the testing set, respectively. The calibration curve and decision curve analyses showed satisfactory consistency and clinical utility of the nomogram. Conclusion: Our results suggest that the combination model built with clinical and radiomics features could reliably predict the occurrence of RP-ILD in MDA5(+) DM patients.

Application of HRCT-based radiomics to predict interstitial lung disease for juvenile dermatomyositis

Clinical Nomogram Assisting in Discrimination of Juvenile Dermatomyositis-Associated Interstitial Lung Disease.

Assessment of Thigh MRI Radiomics and Clinical Characteristics for Assisting in Discrimination of Juvenile Dermatomyositis.

A Computed Tomography Radiomics-Based Prediction Model on Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis

Radiomics based on HRCT can predict RP-ILD and mortality in anti-MDA5 + dermatomyositis patients: a multi-center retrospective study

MDA5 score--A Novel Lung Computed Tomography Scoring Method for Anti-Melanoma Differentiation-associated Gene 5-positive Dermatomyositis

Non-contrast computed tomography-based radiomics for staging of connective tissue disease-associated interstitial lung disease

A Novel CT Scoring Method Predicts the Prognosis of Interstitial Lung Disease Associated with Anti-Mda5 Positive Dermatomyositis

HRCT Features of Dermatomyositis-/Polymyositis- Associated Interstitial Lung Disease

A Nomogram Based on Clinical Factors and CT Radiomics for Predicting Anti-Mda5+ DM Complicated by RP-ILD.

Interstitial Lung Disease in Children: High-Resolution CT Findings in 14 Patients

A nomogram model combining computed tomography-based radiomics and Krebs von den Lungen-6 for identifying low-risk rheumatoid arthritis-associated interstitial lung disease

Title: MDA5 score--A Novel Lung Computed Tomography Scoring Method for Anti-Melanoma Differentiation-associated Gene 5-positive Dermatomyositis

Selection of glucocorticoid-sensitive patients in interstitial lung disease secondary to connective tissue diseases population by radiomics.

A computed tomography-based radiomics nomogram for predicting overall survival in patients with connective tissue disease-associated interstitial lung disease

Severity-stratification of interstitial lung disease by deep learning enabled assessment and quantification of lesion indicators from HRCT images

Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease

The clinical characteristics of interstitial lung disease in patients with dermatomyositis and polymyositis

Predictive Factors and Unfavorable Prognostic Factorial Analysis of Interstitial Lung Disease in Patients with Inflammatory Myopathy

An Approach to the Development of Interstitial Lung Disease in Dermatomyositis: a Study of 230 Cases in China.

Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis